Importantly, four out of ten patients who achieved CR remained disease-free for more than two years after completing treatment, which adds to the body of literature suggesting the possibility of cure with PD-1 inhibitors in cSCC [27]. The gene discussed is PDCD1; the disease is skin squamous cell carcinoma.